CJC-1295 W/Dac – 5mg
$100.00
CJC-1295 with DAC (Drug Affinity Complex) is a powerful synthetic analog of Growth Hormone-Releasing Hormone (GHRH), modified for extreme metabolic stability. By incorporating the DAC moiety, this peptide binds to circulating albumin, extending its half-life from minutes to several days. This makes it an essential tool for researchers studying the long-term effects of sustained, elevated growth hormone levels on tissue repair and metabolic function. Every 2mg vial is vacuum-sealed and guaranteed at 99% purity.
Out of stock
Description
Overview of CJC-1295 with DAC
CJC-1295 with DAC is a 29-amino acid peptide that functions as a functional analog of the endogenous GHRH(1-29) sequence. The defining feature of this compound is the addition of the Drug Affinity Complex (DAC), which allows the peptide to covalently bond to plasma albumin after administration.
While standard GHRH analogs are cleared by the kidneys within 30 minutes, CJC-1295 with DAC remains biologically active in the system for approximately 6–8 days. In a research context, this allows for the study of “constant” rather than “pulsatile” growth hormone elevation, providing a unique window into the long-term physiological shifts in the somatotropic axis.
Primary Research Applications
This formulation is a cornerstone of endocrinology and longevity research, utilized to explore:
-
Sustained GH Elevation: Investigating the biological impact of non-pulsatile, steady-state increases in Growth Hormone and IGF-1 (Insulin-like Growth Factor 1).
-
Metabolic Optimization: Researching the peptide’s role in upregulating protein synthesis and enhancing the oxidation of adipose tissue over extended periods.
-
Tissue and Nerve Regeneration: Studying the effects of prolonged GHRH activation on the repair of deep-tissue injuries and peripheral nerve damage.
-
Sleep and Circadian Biology: Analyzing how exogenous GHRH analogs influence deep sleep (slow-wave sleep) patterns in animal models.
